Publications by authors named "Daniel Hollern"

Claim this Profile
D
DAB2IP loss in luminal a breast cancer leads to NF-κB-associated aggressive oncogenic phenotypes.
Angana Mukherjee, Rasha T Kakati, Sarah Van Alsten, Tyler Laws, Aaron L Ebbs, Daniel P Hollern

JCI Insight· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insight into mammary gland development and tumor progression in an E2F5 conditional knockout mouse model.
Briana To, Carson Broeker, Jing-Ru Jhan, Jesus Garcia-Lerena, John Vusich, Daniel Hollern

Oncogene· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memory B cell fitness and anergy has significant links to cancer lethality.
Daniel Hollern

Cell· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Evolving Landscape of B Cells in Cancer Metastasis.
Monika J Ramos, Asona J Lui, Daniel P Hollern

Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated phosphorylation of EGFR in NSCLC due to mutations in PTPRH.
Matthew R Swiatnicki, Jonathan P Rennhack, Mylena M O Ortiz, Daniel P Hollern, Ashlee V Perry

PLoS Genet· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities.
Céline M Laumont, Allyson C Banville, Mara Gilardi, Daniel P Hollern, Brad H Nelson

Nat Rev Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer.
Swarnima Singh, Nigel Lee, Diego A Pedroza, Igor L Bado, Clark Hamor, Daniel Hollern

Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microneedle-mediated Intratumoral Delivery of Anti-CTLA-4 Promotes cDC1-dependent Eradication of Oral Squamous Cell Carcinoma with Limited irAEs.
Mara Gilardi, Robert Saddawi-Konefka, Victoria H Wu, Miguel Angel Lopez-Ramirez, Zhiyong Wang, Daniel P Hollern

Mol Cancer Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathway.
Feng Bai, Chuying Wang, Xiong Liu, Daniel Hollern, Shiqin Liu

Cell Death Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cells secrete GABA, which provokes a pro-tumor immune microenvironment.
Mara Gilardi, Monika Ramos, Daniel Hollern

Cancer Cell· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA.
Joseph P Garay, Rebecca Smith, Kaylyn Devlin, Daniel P Hollern, Tiera Liby

Breast Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXA1 overexpression suppresses interferon signaling and immune response in cancer.
Yundong He, Liguo Wang, Ting Wei, Yu-Tian Xiao, Haoyue Sheng, Daniel P Hollern

J Clin Invest· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors.
Feng Bai, Shiqin Liu, Xiong Liu, Daniel P Hollern, Alexandria Scott

Breast Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease.
Susana Garcia-Recio, Aatish Thennavan, Michael P East, Joel S Parker, Juan M Cejalvo, Daniel P Hollern

J Clin Invest· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer.
Erika J Crosby, Chaitanya R Acharya, Anthony-Fayez Haddad, Christopher A Rabiola, Gangjun Lei, Daniel P Hollern

Clin Cancer Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21 overexpression, which is reversed by metformin.
Mark Williams, Xinhui Liu, Yueqi Zhang, Jake Reske, Devika Bahal, Daniel Hollern

Oncogene· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virus expression detection reveals RNA-sequencing contamination in TCGA.
Sara R Selitsky, David Marron, Daniel Hollern, Lisle E Mose, Katherine A Hoadley

BMC Genomics· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer.
Daniel P Hollern, Nuo Xu, Aatish Thennavan, Cherise Glodowski, Susana Garcia-Recio

Cell· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E2F1 Drives Breast Cancer Metastasis by Regulating the Target Gene FGF13 and Altering Cell Migration.
Daniel P Hollern, Matthew R Swiatnicki, Jonathan P Rennhack, Sean A Misek, Brooke C Matson

Sci Rep· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer.
Daniel P Hollern, Cristina M Contreras, Stephanie Dance-Barnes, Grace O Silva, Adam D Pfefferle

Breast Cancer Res Treat· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer.
Maki Tanioka, Kevin R Mott, Daniel P Hollern, Cheng Fan, David B Darr

Genome Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast.
Yeji An, Jessica R Adams, Daniel P Hollern, Anthony Zhao, Stephen G Chang

Cell Rep· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Regulation of Development and Possible Roles in Cancer Progression and Metastasis.
Angana Mukherjee, Daniel P Hollern, Oluwasina G Williams, Tyeler S Rayburn, William A Byrd

Front Cell Dev Biol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Molecular Characterization of Testicular Germ Cell Tumors.
Hui Shen, Juliann Shih, Daniel P Hollern, Linghua Wang, Reanne Bowlby

Cell Rep· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histological subtypes of mouse mammary tumors reveal conserved relationships to human cancers.
Daniel P Hollern, Matthew R Swiatnicki, Eran R Andrechek

PLoS Genet· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis